Dr. Judy and the founders of CYTOGEN MD™, Andrew, and René Serafini, met towards the end of 2014 working in the natural health industry.  With a shared love for healing people and understanding the therapeutic nature of cannabinoids, Dr. Judy and the Serafini’s have spent several years educating clients while collaborating on producing the highest quality CBD-based products available.  Judy’s love for natural products chemistry and understanding the pathology behind most disease states has provoked the creation of products that take advantage of synergies while targeting the body’s most extensive receptor system – the Endocannabinoid System.

More than 26,000 studies show the potential and promise of cannabinoids for the management of 50 health conditions.  Recent research shows the profound ability cannabinoids have for the prevention and possible treatment of CV19.  CBD and other minor cannabinoids like CBDa and CBGa have been shown to inhibit the ACE-2 pathway where the Sars-CoV-2 virus makes entry into the cell.  Research is still early, but initial studies show tremendous promise.